Rankings
▼
Calendar
INVA FY 2017 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$217M
+62.6% YoY
Gross Profit
$216M
99.4% margin
Operating Income
$184M
84.5% margin
Net Income
$134M
61.8% margin
EPS (Diluted)
$1.17
Cash Flow
Operating Cash Flow
$142M
Free Cash Flow
$142M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$367M
Total Liabilities
$610M
Stockholders' Equity
-$243M
Cash & Equivalents
$73M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$217M
$134M
+62.6%
Gross Profit
$216M
$132M
+63.3%
Operating Income
$184M
$109M
+68.5%
Net Income
$134M
$60M
+125.3%
← Q4 2016
All Quarters
Q1 2017 →